Ati cautat: monitorizare incidenta cancer
Protocol terapeutic: L005C – DCI ACIDUM PAMIDRONICUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: M003M – OSTEOPOROZA – ACIDUM ALENDRONICUM**; ACIDUM RISEDRONICUM**; ACIDUM ZOLENDRONICUM**; COMBINAŢII (ACIDUM ALENDRONICUM + COLECALCIFEROLUM)**; DENOSUMABUM(Prolia)**; TERIPARATIDUM**(original si biosimilar) (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L003C – DCI FULVESTRANTUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: G005N – DCI LEVONORGESTRELUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A001E – DCI ORLISTATUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Sesiunea Stiintifica a Institutului de Pneumoftiziologie Marius Nasta – 11 aprilie 2014
